1. CX3CL1: a potential chemokine widely involved in the process spinal metastases
   WangMi Liu et al, 2017, Oncotarget CrossRef
2. Fractalkine/CX3CL1 in Neoplastic Processes
   Jan Korbecki et al, 2020, International Journal of Molecular Sciences CrossRef
3. A prospective study of immune and inflammation markers and risk of lung cancer among female never smokers in Shanghai
   Meredith S Shiels et al, 2017, Carcinogenesis CrossRef
4. Longitudinal patterns of inflammatory mediators after acute HIV infection correlate to intact and total reservoir
   Jozefien De Clercq et al, 2024, Frontiers in Immunology CrossRef
5. Patrolling monocytes control tumor metastasis to the lung
   Richard N. Hanna et al, 2015, Science CrossRef
6. CX3CR1 identifies PD-1 therapy–responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy
   Yiyi Yan et al, 2018, JCI Insight CrossRef
7. How chemokines organize the tumour microenvironment
   Thorsten R. Mempel et al, 2024, Nature Reviews Cancer CrossRef
8. CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis
   Dariusz Szukiewicz, 2024, International Journal of Molecular Sciences CrossRef
9. MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer
   Yanli He et al, 2015, Scientific Reports CrossRef
10. Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer
    Ana Bocanegra et al, 2023, EMBO reports CrossRef
11. Circulating inflammation markers and prostate cancer
    Henrik Ugge et al, 2019, The Prostate CrossRef
12. CX3CL1 as potential immunotherapeutic tool for bone metastases in lung cancer: A preclinical study
    Charlotte Cohen et al, 2022, Advances in Cancer Biology - Metastasis CrossRef
13. The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing CancerIn VitroandIn Vivo
    Tobias F. Dreyer et al, 2021, Cancer Immunology Research CrossRef
14. CX3CR1–CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment
    Takayoshi Yamauchi et al, 2020, JCI Insight CrossRef